Dose-Response Relationship, Immunologic
-
Subject Areas on Research
-
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
-
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
-
Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes.
-
Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
-
Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine.
-
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
-
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.
-
Anti-mouse mesangial cell serum induces acute glomerulonephropathy in mice.
-
Anti-receptor antibody-induced H-Y-specific delayed-type hypersensitivity responses in nonresponder mice.
-
Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
-
Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
-
Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
-
B lymphocytes differentially influence acute and chronic allograft rejection in mice.
-
CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study.
-
CD4+Thy1- thymocytes with a Th-type 2 cytokine response.
-
Characterization and affinity isolation of xenoreactive human natural antibodies.
-
Characterization of human chemotactic lymphokine production induced by mitogens and mixed leukocyte reactions using a new microassay.
-
Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
-
Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.
-
Control of idiotope expression by monoclonal anti-idiotope and idiotope-bearing antibody.
-
Corneal organ cultures in tyrosinemia release chemotactic factors.
-
Depression, urinary free cortisol excretion and lymphocyte function.
-
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape.
-
Effectiveness of measles vaccination and vitamin A treatment.
-
Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.
-
Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
-
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
-
Genetic control of peripheral leukocyte response to endotoxin in mice.
-
Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H2-linked genes in the control of the anti-nuclease antibody response.
-
High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes.
-
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance.
-
Histone deacetylation critically determines T cell subset radiosensitivity.
-
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
-
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
-
Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.
-
Humoral immune responses in Cr2-/- mice: enhanced affinity maturation but impaired antibody persistence.
-
Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide.
-
ICAM-1 (CD54) expression on B lymphocytes is associated with their costimulatory function and can be increased by coactivation with IL-1 and IL-7.
-
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
-
Immunization of normal human splenocytes in vitro to produce human monoclonal antibodies to cellular antigens.
-
Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.
-
Impaired lymphocyte function in depressive illness.
-
Individualization of gamma globulin dosage in patients with humoral immunodeficiency.
-
Induction of protective CTL responses in newborn mice by a murine retrovirus.
-
Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men. The Multicenter AIDS Cohort Study.
-
Inhibition of in vitro NZB antibody responses by cyclosporine.
-
Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody.
-
Ir genes of different high responder haplotypes for staphylococcal nuclease are not allelic.
-
Kinetics of TCR use in response to repeated epitope-specific immunization.
-
Ligation of cell surface-associated glucose-regulated protein 78 by receptor-recognized forms of alpha 2-macroglobulin: activation of p21-activated protein kinase-2-dependent signaling in murine peritoneal macrophages.
-
Lymphocyte responses to purified ragweed allergens in vitro. I. Proliferative responses in normal, newborn, agammaglobulinemic, and atopic subjects.
-
Lymphocyte responses to ragweed antigens from different sources.
-
Mapping of a ligand-binding site for the human thromboxane A2 receptor protein.
-
Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
-
Modulation of lymphocyte functions by group A streptococcal membrane.
-
Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
-
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
-
Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages.
-
Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
-
Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
-
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.
-
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.
-
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.
-
Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1.
-
Regulation of complement activity by vaccinia virus complement-control protein.
-
SMAD4 is required for development of maximal endotoxin tolerance.
-
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.
-
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
-
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
-
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.
-
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
-
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.
-
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.
-
Surfactant protein A regulates complement activation.
-
The biological activity of a liposomal complete core lipopolysaccharide vaccine.
-
The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.
-
The induction of tolerance and suppression in autoimmune MRL mice using hapten-modified self.
-
The requirement of reversible cysteine sulfenic acid formation for T cell activation and function.
-
The role of complement in the induction of antibody responses.
-
The role of leukotriene B4 in Clostridium difficile toxin A-induced ileitis in rats.
-
Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma.
-
Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
-
Variation in DNA and RNA synthetic responses during activation of lymphocytes from inbred strains of mice.
-
Keywords of People
-
Bowes Rickman, Catherine,
Professor of Ophthalmology,
Cell Biology
-
Farsiu, Sina,
Paul Ruffin Scarborough Associate Professor of Engineering,
Electrical and Computer Engineering
-
Weinhold, Kent James,
Joseph W. and Dorothy W. Beard Professor of Experimental Surgery, in the School of Medicine,
Immunology